Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Abstract Background Programmed cell death ligand 1 (PD-L1) is a potential predictive biomarker of the response to anti-PD-L1/anti- programmed cell death 1 (PD-1) therapy in multiple cancers, including triple negative breast cancer(TNBC). The purpose of this study was to investigate whether PD-L1 exp...

Full description

Bibliographic Details
Main Authors: Ming Li, Anqi Li, Shuling Zhou, Yan Xu, Yaoxing Xiao, Rui Bi, Wentao Yang
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
Triple negative breast cancer
PD-L1
Lymph node metastasis
Heterogeneity
Online Access:http://link.springer.com/article/10.1186/s12885-017-3916-y

Internet

http://link.springer.com/article/10.1186/s12885-017-3916-y

Similar Items